Glioma patients whose tumors were hypermutated showed no significant benefit when treated with checkpoint blockers.
Combining niacin, or vitamin B3, with chemotherapy, helped slow the progression and increase life span in mouse models of glioblastoma.
Lipids responsible for neural function are highly active and not inert. The findings challenge traditional beliefs about mature myelin.
Manipulating gut bacteria in mice before chemotherapy reduces the mental fog of "chemo brain."
A study shows that postoperative radiation improves outcomes for children with ependymoma, even those with historically poor prognoses and the very young.
A newly developed AI is able to identify and predict the development of a combination of symptoms associated with chemotherapy.
Researchers have developed a new approach that uses microRNA in combination with chemotherapy to help treat glioblastoma brain cancer. In preclinical models, the approach increases survival of the deadly brain cancer five fold.
Researchers report a targeted therapy that blocks LSD1 effectively shrinks tumor size in mouse models of medulloblastoma, a form of pediatric brain cancer.
Researchers report our gender can determine longevity and response to treatment for glioblastoma brain cancer. The study reports male survival is determined by genes that control cell division, where as female survival is often determine by genes that regulate the ability of cancer cells to migrate to different brain areas.
Researchers have identified the 3D structure of a brain receptor that causes vomiting and nausea as a result of chemotherapy treatments for cancer. The same receptor also plays a critical role in pain perception, migraines and chronic itching.
A new study reveals distinct molecular differences in signatures of glioblastoma brain cancer between men and women. Researchers report current treatments for the brain cancer are more effective in women than in men. The findings could help to tailor treatments aimed at the different sexes and improve survival.
Researchers use focused ultrasound to safely and non-invasively open the blood-brain barrier in Alzheimer's patients.
